To explore the potential mechanisms of IL-22 which inhibited the OVA-induced airway inflammation, we performed immunohistochemistry to detect the expression of functional IL-22 receptor, a heterodimer of IL-22RA1 and IL-10RB, and its soluble binding protein, IL-22BP. The gene discussed is IL22RA2; the disease is inflammation.